CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Iridex reaffirms 2026 revenue guidance of $51m-$53m while highlighting working-capital build tied to headquarters relocation

EarningsNeutral
AI Analysis

Summary

Iridex reaffirmed its 2026 revenue guidance of $51m-$53m while noting working-capital impacts from its headquarters relocation.

Financial Highlights

Guidance

$51m-$53m

Importance:2/10
Sentiment:
0.00
guidance_reaffirmationrevenue_guidanceworking_capitalheadquarters_relocation
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on August 19, 2026 12:02 AM

Read Original